Orpea S.A.

As of December 31, 2023, Orpea S.A. has 130.74M shares outstanding.

These figures are as of December 31, 2023. The EV/Sales ratio of 1.64 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Orpea S.A. trades at an EV/FCF ratio of 9.17, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of December 31, 2023, Orpea S.A. maintains a current ratio of 0.76, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 485.11, indicating elevated leverage, while an interest coverage ratio of -0.21 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2023. Return on invested capital (ROIC) is negative at -0.98, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 9.54, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 18.00, useful for judging operating efficiency across full business cycles. Inventory turnover of 67.74 indicates how many times Orpea S.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended December 31, 2023. That works out to an effective tax rate of 3.18, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

Over the twelve months ended December 31, 2023, Orpea S.A. posted a gross margin of 79.36, reflecting its pricing power and cost economics. The operating margin of -2.32 and net profit margin of 26.07 provide insight into operational efficiency.

Orpea S.A.'s most recent stock split took place on March 22, 2024 with a 1000:1 split ratio.

As of December 31, 2023, Orpea S.A. has an Altman Z-Score of 0.53, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.